Détails sur le projet
Description
PROJECT NARRATIVE
Cancer immunotherapies have demonstrated significant clinical success for subgroups of patients with varying
malignancies. However, due in part to their systemic administration, therapeutic limitations include immune-
related adverse effects and diminished efficacy due to poor tumor penetration. This proposal seeks to engineer
immunotherapeutic probiotic bacteria that target primary cancers and associated metastases and locally deliver
immunotherapy and adjuvants to stimulate systemic antitumor immunity with minimal side effects.
Statut | Terminé |
---|---|
Date de début/de fin réelle | 1/21/20 → 12/31/22 |
Financement
- National Cancer Institute: 1 152 227,00 $ US
- National Cancer Institute: 596 099,00 $ US
Keywords
- Inmunología
- Oncología
Empreinte numérique
Explorer les sujets de recherche abordés dans ce projet. Ces étiquettes sont créées en fonction des prix/bourses sous-jacents. Ensemble, ils forment une empreinte numérique unique.